PHARMACEUTICAL AND BASIC MEDICAL SCIENCES IV

Back

Learning Outcomes

Will be able to evaluate infectious diseases.
• Lists microbial diseases by airway. • Explains the factors of microbial diseases passing through the airway. • Lists microbial diseases passing by direct contact. • Explains the sources of microbial diseases passing by direct contact. • Lists sexually transmitted infections. • Explains the factors of sexually transmitted microbial diseases. • Lists viral diseases transmitted through animals. • Explains the factors of viral diseases carried by animals. • Lists bacterial and viral diseases transported through arthropod. • Explains the bacterial and viral diseases caused by arthropod. • Lists bacterial diseases caused by soil. • Explains the bacterial diseases caused by soil. • Lists diseases of water origin. • Describes waterborne disease factors. • Lists foodborne diseases. • Explains foodborne disease factors.
Will be able to evaluate cancer disease.
• Explains the proliferation of the tumor cell. • Counts the morphological features of the tumor cell. • Counts tumor types. • Describes the features of benign tumor and malignant tumor. • Describes the changes in the cell cycle of tumor cells. • Defines primary and secondary tumors. • Defines angiogenesis. • Explains the formation of angiogenesis. • Counts the cancer types depending on the tissue type. • Lists chemical factors. • Explains the mechanism of action of chemical agents. • Lists physical factors.
Will able to evaluate cancer mechanisms.
• Explains the mechanism of action of chemical agents. • Lists physical factors. • Explains the mechanism of action of physical factors. • Explains genetic factors. • Explains the genetic aspect of cancer formation. • Gives examples of cancers with genetic origin. • Counts the stages of cancer formation. • Explains the transformation of normal cells into tumor cells. • Explains tumor spreading mechanism. • Explains the relationship between tumor and immune system. • Counts the formation steps of metastasis. • Explains tumor invasion mechanism. • Counts the enzymes used by tumor cells in invasion. • Lists the methods used in cancer treatment. • Explains the objectives of the methods. • Explains the effects of treatment. • Lists cell death types. • Defines cell death programs. • Describes the programmed cell death mechanism. • Counts the control points of the programmed cell mechanism. • Compares other cell deaths with programmed cell death.
Will able to evaluate anatomy of the respiratory system.
• Explains nasal cartilage and functional parts of nasal cavity. • Lists the paranasal sinuses opening into the nasal cavity. • Lists larynx sorts cartilage and muscles. • Explains the anatomical features of trachea and bronchi. • Lists the location and neighborhood of the lungs. • Explains the membranes (pleura) that surround the lungs. • Lists the structures in the Mediastinum posterior.
Will able to evaluate the physiology of the respiratory system.
• Explains the mechanics of lung ventilation. • Explains lung volume and capacity features. • Calculates the minute breathing volume using the breath volume and breathing rate. • Explains the concept of alveolar ventilation. • Discusses the functions of the respiratory tract. • Classifies the pulmonary circulatory system physiologically. • Explains the pressures in the pulmonary system. • Explains the blood volume of the lungs. • Discusses the blood flow and distribution in the lungs. • Discusses the effect of hydrostatic pressure differences in the lungs on regional pulmonary blood flow. • Explains pulmonary capillary dynamics. • Describes the properties of the fluid in the pleural cavity. • Discusses the gas diffusion and physics of gas partial pressures. • Explains the difference of alveolar air and atmospheric air combinations. • Explains the expiration air by associating it with dead space air and alveolar air. • Describes the effect of ventilation-perfusion rate on the gas concentration in the alveolar. • Explains the transport of oxygen from the lungs to the body tissues. • Explains the transportation of carbon dioxide in the blood. • Explains the concept of respiratory change rate. • Describes the respiratory center. • Discusses the chemical control of respiration. • Explains the role of the peripheral chemoreceptor system in the control of respiratory activity. • Explains the role of oxygen in breathing control. • Discusses the physiological regulation of breathing during exercise. • Analyzes other factors that affect breathing. • Classifies respiratory abnormalities. • Explains the pathophysiology of specific pulmonary abnormalities. • Explains the concept of hypoxia. • Explains the concept of hypercapnia.
Will able to evaluate the chemotherapeutic drugs from a pharmacological perspective.
• Explains the basic concepts of chemotherapy. • Explains the concept of antimicrobial spectrum. • Gives examples of broad and narrow spectrum drugs. • Explains the development of drug resistance. • Explains the effects of resistance development in terms of clinical application. • Discusses chemotherapeutic drug selection approaches. • Distinguishes pharmacodynamic parameters that determine antimicrobial efficacy. • Distinguishes pharmacokinetic parameters that determine antimicrobial efficacy. • Discusses the causes of failure in antimicrobial therapy. • Explains the concept of chemoprophylaxis. • Gives examples of chemoprophylaxis applications.
• Classifies beta-lactam antibiotics. • Classifies penicillins. • Distinguishes antimicrobial spectra of penicillins. • Explains the pharmacokinetic properties of penicillins. • Explains the mechanism of action of penicillins. • Distinguishes the indications of penicillins. • Gives examples of penicillins for indications. • Describes the side effects of penicillins. • Explains the contraindications of penicillins. • Classifies cephalosporins. • Distinguishes antimicrobial spectra of cephalosporins. • Explains the pharmacokinetic properties of cephalosporins. • Explains the mechanism of action of cephalosporins. • Distinguishes the indications of cephalosporins. • Gives examples to cephalosporins for indications. • Describes the side effects of cephalosporins. • Describes contraindications of cephalosporins. • Classifies other beta-lactam antibiotics. • Distinguishes antimicrobial spectra of other beta-lactam antibiotics. • Describes the pharmacokinetic properties of other beta-lactam antibiotics. • Describes the mechanism of action of other beta-lactam antibiotics. • Distinguishes indications of other beta-lactam antibiotics. • Gives examples of other beta-lactam antibiotics for indications for use. • Describes the side effects of other beta-lactam antibiotics. • Describes contraindications of other beta-lactam antibiotics.
• Classifies macrolide, linkosamide, streptogramin Antibiotics, and linezolid. • Distinguishes the antimicrobial spectra of macrolide, linkosamide, streptogramin antibiotics, and linezolid. • Describes the pharmacokinetic properties of macrolide, lincosamide, streptogramin antibiotics, and linezolid. • Describes the mechanisms of action of macrolide, lincosamide, streptogramin antibiotics, and linezolid. • Distinguishes the indications of macrolide, linkosamide, streptogramin antibiotics, and linezolid. • Gives examples of this group of drugs for indications for use. • Describes the side effects of macrolide, lincosamide, streptogramin antibiotics and linezolid. • Describes the contraindications of macrolide, linkosamide, streptogramin antibiotics, and linezolid. • Classifies tetracyclines. • Distinguishes the antimicrobial spectra of tetracyclines. • Explains the pharmacokinetic properties of tetracyclines. • Explains the mechanism of action of tetracyclines. • Distinguishes the indications of tetracyclines. • Gives examples to tetracyclines for indications. • Describes the side effects of tetracyclines. • Explains the contraindications of tetracyclines. • Classifies amphenicol. • Distinguishes the antimicrobial spectra of amphenicol. • Explains the pharmacokinetic properties of amphenicol. • Explains the mechanism of action of amphenicol. • Distinguishes the indications of amphenicol. • Gives examples to amphenicols for indications. • Describes the side effects of amphenicol. • Explains the contraindications of amphenicol.
• Classifies aminoglycosides. • Distinguishes the antimicrobial spectra of aminoglycosides. • Describes the pharmacokinetic properties of aminoglycosides. • Explains the mechanism of action of aminoglycosides. • Distinguishes the indications of aminoglycosides. • Gives examples of aminoglycosides for indications. • Describes the side effects of aminoglycosides. • Describes the contraindications of aminoglycosides. • Classifies antistaphylococcal drugs. • Distinguishes antimicrobial spectra of antistaphylococcal drugs. • Describes the pharmacokinetic properties of antistaphylococcal drugs. • Explains the mechanism of action of antistaphylococcal drugs. • Distinguishes the indications of antistaphylococcal drugs. • Gives an example of antistaphylococcal drugs for the indications for which it is used. • Describes the side effects of antistaphylococcal drugs. • Describes the contraindications of antistaphylococcal drugs. • Classifies antianaerobic drugs. • Distinguishes antimicrobial spectra of antianaerobic drugs. • Describes the pharmacokinetic properties of antianaerobic drugs. • Explains the mechanisms of action of antianaerobic drugs. • Distinguishes the indications of antianaerobic drugs. • Gives an example of antianaerobic drugs for the indications for which it is used. • Describes the side effects of antianaerobic drugs. • Describes the contraindications of antianaerobic drugs. • Classifies polypeptide structured drugs. • Distinguishes the antimicrobial spectra of polypeptide structured drugs. • Explains the pharmacokinetic properties of polypeptide drugs. • Explains the mechanism of action of drugs with polypeptide structure. • Distinguishes the indications of polypeptide structured drugs. • Gives examples of drugs with polypeptide structure for indications. • Describes the side effects of polypeptide drugs. • Explains the contraindications of polypeptide drugs.
• Classifies fluoroquinolones. • Distinguishes the antimicrobial spectra of fluoroquinolones. • Explains the pharmacokinetic properties of fluoroquinolones. • Explains the mechanism of action of fluoroquinolones. • Distinguishes the indications of fluoroquinolones. • Gives an example of fluoroquinolones for the indications for which it is used. • Describes the side effects of fluoroquinolones. • Describes the contraindications of fluoroquinolones. • Classifies sulfonamides. • Distinguishes antimicrobial spectra of sulfonamides. • Describes the pharmacokinetic properties of sulfonamides. • Explains the mechanism of action of sulfonamides. • Distinguishes the indications of sulfonamides. • Gives examples to sulfonamides for indications. • Describes the side effects of sulfonamides. • Describes the contraindications of sulfonamides. • Distinguishes the antimicrobial spectrum of co-trimoxazole. • Explains the pharmacokinetic properties of co-trimoxazole. • Explains the mechanism of action of co-trimoxazole. • Distinguishes the indications of co-trimoxazole. • Describes the side effects of co-trimoxazole. • Describes the contraindications of sulfonamides. • Distinguishes the antimicrobial spectrum of trimethoprim. • Explains the pharmacokinetic properties of trimethoprim. • Explains the mechanisms of action of trimethoprim. • Distinguishes the indications of trimethoprim. • Describes the side effects of trimethoprim.
• Classifies antifungal drugs. • Distinguishes antimicrobial spectra of antifungal drugs. • Describes the pharmacokinetic properties of antifungal drugs. • Explains the mechanisms of action of antifungal drugs. • Distinguishes the indications of antifungal drugs. • Gives examples of antifungal drugs for the indications for which it is used. • Describes the side effects of antifungal drugs. • Explains the contraindications of antifungal drugs. • Classifies the drugs used in tuberculosis and other mycobacterial infections. • Distinguishes antimicrobial spectra of drugs used in tuberculosis and other mycobacterial infections. • Describes the pharmacokinetic properties of drugs used in tuberculosis and other mycobacterial infections. • Describes the mechanism of action of drugs used in tuberculosis and other mycobacterial infections. • Distinguishes the indications of drugs used in tuberculosis and other mycobacterial infections. • Describes the side effects of drugs used in tuberculosis and other mycobacterial infections. • Describes the contraindications of drugs used in tuberculosis and other mycobacterial infections. • Classifies the drugs used in the treatment of urinary infections. • Distinguishes antimicrobial spectra of drugs used in the treatment of urinary infections. • Describes the pharmacokinetic properties of drugs used in the treatment of urinary infections. • Describes the mechanism of action of drugs used in the treatment of urinary infections. • Distinguishes the indications of drugs used in the treatment of urinary infections. • Gives examples of drugs used in the treatment of urinary infections for the indications for which it is used. • Describes the side effects of drugs used in the treatment of urinary infections. • Describes the contraindications of the drugs used in the treatment of urinary infections.
• Classifies antiamibic and antiprotozoal drugs. • Distinguishes antimicrobial spectra of antiamibic and antiprotozoal drugs. • Describes the pharmacokinetic properties of antiamibic and antiprotozoal drugs. • Explains the mechanisms of action of antiamibic and antiprotozoal drugs. • Distinguishes the indications of antiamibic and antiprotozoal drugs. • Gives examples of antiamibic and antiprotozoal drugs used for indications. • Describes the side effects of antiamibic and antiprotozoal drugs. • Describes the contraindications of antiamibic and antiprotozoal drugs. • Classifies antimalarial drugs. • Distinguishes antimicrobial spectra of antimalarial drugs. • Describes the pharmacokinetic properties of antimalarial drugs. • Explains the mechanisms of action of antimalarial drugs. • Distinguishes the indications of antimalarial drugs. • Gives an example of antimalarial drugs for the indications for which it is used. • Describes the side effects of antimalarial drugs. • Explains the contraindications of antimalarial drugs. • Classifies anthelmintic drugs. • Distinguishes antimicrobial spectra of anthelmintic drugs. • Describes the pharmacokinetic properties of anthelmintic drugs. • Explains the mechanisms of action of anthelmintic drugs. • Distinguishes the indications of anthelmintic drugs. • Gives an example of anthelmintic drugs for the indications for which it is used. • Describes the side effects of anthelmintic drugs. • Describes the contraindications of anthelmintic drugs.
• Categorizes drug used against ectoparasites. • Distinguishes antimicrobial spectra of drugs used against ectoparasites. • Explains the pharmacokinetic properties of drugs used against ectoparasites. • Explains the mechanism of drugs used against ectoparasites. • Distinguishes the indications of drugs used against ectoparasites. • Gives examples drugs used against ectoparasites. • Defines the side effects of drugs used against ectoparasites. • Explains the contraindications of drugs used against ectoparasites. • Classifies antiviral drugs. • Distinguishes antimicrobial spectra of antiviral drugs. • Describes the pharmacokinetic properties of antiviral drugs. • Explains the mechanisms of action of antiviral drugs. • Distinguishes the indications of antiviral drugs. • Gives examples of antiviral drugs for the indications for which it is used. • Describes the side effects of antiviral drugs. • Describes the contraindications of antiviral drugs. • Classifies antiseptic and disinfectant drugs. • Distinguishes antimicrobial spectra of antiseptic and disinfectants. • Explains the mechanism of action of antiseptic and disinfectants.
• Indicates the main principle of antineoplastic therapy. • Explains the multimodel treatment method. • Interprets the therapeutic indices of antineoplastic drugs. • Counts and explains the factors that limit the effectiveness of drugs in antineoplastic chemotherapy. • Defines the term apoptosis, explains apoptotic processes. • Explains primary chemotherapy. • Explains adjuvant chemotherapy. • Explains neoadjuvant chemotherapy. • Explains concomitant chemotherapy. • Classifies cytotoxic drugs. • Describes the pharmacokinetic properties of cytotoxic drugs. • Explains the mechanism of action of cytotoxic drugs. • Distinguishes the indications of cytotoxic drugs. • Gives examples of cytotoxic drugs for indications. • Describes the side effects of cytotoxic drugs. • Describes the contraindications of cytotoxic drugs. • Classifies hormones and hormone antagonists. • Explains the pharmacokinetic properties of hormones and hormone antagonists. • Explains the mechanism of action of hormones and hormone antagonists. • Distinguishes the indications of hormones and hormone antagonists. • Gives examples of cytotoxic drugs for indications. • Describes the side effects of hormones and hormone antagonists. • Explains the contraindications of hormones and hormone antagonists. • Explains the use of radioisotopes in cancer treatment. • Explains the use of immunotherapy in cancer treatment. • Describes the use of biological response modifiers in cancer treatment. • Explains the use of immunotherapeutics in cancer treatment.
Will able to evaluate the respiratory system drugs from a pharmacological perspective.
• Classifies antitussive drugs. • Describes the pharmacokinetic properties of antitussive drugs. • Explains the mechanisms of action of antitussive drugs. • Distinguishes the indications of antitussive drugs. • Gives examples of antitussive drugs for indications. • Describes the side effects of antitussive drugs. • Explains the contraindications of antitussive drugs. • Categorizes the expectorant drugs. • Explains the pharmacokinetic properties of expectorant drugs. • Explains the mechanism of action of expectorant drugs. • Distinguishes indications of expectorants. • Gives examples of expectorant drugs for the indications for which it is used. • Describes the side effects of expectorant drugs. • Explains the contraindications of expectorant drugs. • Classifies mucolytic drugs. • Describes the pharmacokinetic properties of mucolytic drugs. • Explains the mechanism of action of mucolytic drugs. • Distinguishes the indications of mucolytic drugs. • Gives examples of mucolytic drugs for indications. • Describes the side effects of mucolytic drugs. • Describes the contraindications of mucolytic drugs. • Classifies surfactant drugs. • Explains the pharmacokinetic properties of surfactants. • Explains the mechanism of action of surfactants. • Distinguishes the indications of surfactants. • Gives examples to surfactants for the indications for which it is used. • Describes the side effects of surfactants. • Explains the contraindications of surfactants.
• Classifies bronchodilator drugs and other anti-asthmatic drugs. • Describes the pharmacokinetic properties of bronchodilator drugs and other anti-asthmatic drugs. • Describes the mechanism of action of bronchodilator drugs and other anti-asthmatic drugs. • Distinguishes the indications of bronchodilator drugs and other anti-asthmatic drugs. • Gives examples of bronchodilator drugs and other anti-asthmatic drugs for the indications for which it is used. • Describes the side effects of bronchodilator drugs and other anti-asthmatic drugs. • Describes the contraindications of bronchodilator drugs and other anti-asthmatic drugs. • Classifies oxygen and other treatment gases. • Summarizes the pharmacological properties of oxygen and other treatment gases.
Will able to evaluate the chemotherapeutic drugs from a toxicological perspective.
• Counts the adverse effects induced by penicillins. • Describes the mechanism of adverse effects induced by penicillins. • Explains the risk factors for adverse effects induced by penicillins. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by cephalosporins. • Describes the mechanism of adverse effects induced by cephalosporins. • Explains risk factors for adverse effects induced by cephalosporins. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by imipenem, meropenem, doripenem, and ertapenem. • Describes the mechanism of imipenem, meropenem, doripenem and ertapenem-induced adverse effects. • Describes risk factors in adverse effects induced by imipenem, meropenem, doripenem and ertapenem. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by macrolides. • Describes the mechanism of adverse effects induced by macrolides. • Explains the risk factors for adverse effects induced by macrolides. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by tetracyclines. • Explains the mechanism of adverse effects induced by tetracyclines. • Explains risk factors for adverse effects induced by tetracyclines. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions.
• Counts the adverse effects induced by amphenicols. • Explains the mechanism of adverse effects induced by amphenicol. • Explains the risk factors for adverse effects induced by amphenicol. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by aminoglycosides. • Describes the mechanism of adverse effects induced by aminoglycosides. • Explains risk factors for adverse effects induced by aminoglycosides. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by antistaphylococcal drugs. • Describes the mechanism of adverse effects induced by antistaphylococcal drugs. • Explains risk factors for adverse effects induced by antistaphylococcal drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by antianaerobic drugs. • Describes the mechanism of adverse effects induced by antianaerobic drugs. • Explains risk factors for adverse effects induced by antianaerobic drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by polypeptide structured antibiotics. • Describes the mechanism of adverse effects induced by polypeptide antibiotics. • Explains risk factors for adverse effects induced by polypeptide antibiotics. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by fluoroquinolones. • Describes the mechanism of adverse effects induced by fluoroquinolones. • Explains risk factors for adverse effects induced by fluoroquinolones. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by sulfonamides. • Describes the mechanism of adverse effects induced by sulfonamides. • Describes risk factors in adverse effects induced by sulfonamides. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by co-trimoxazole. • Explains the mechanism of adverse effects induced by co-trimoxazole. • Explains the risk factors for adverse effects induced by co-trimoxazole. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts trimethoprim-induced adverse effects. • Describes the mechanism of adverse effects induced by trimethoprim. • Describes the risk factors for adverse effects induced by trimethoprim. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions.
• Counts the adverse effects induced by antifungal drugs. • Explains the mechanism of adverse effects induced by antifungal drugs. • Explains the risk factors for adverse effects induced by antifungal drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by drugs used in tuberculosis and other mycobacterial infections. • Describes the mechanism of adverse effects induced by drugs used in tuberculosis and other mycobacterial infections. • Describes risk factors in adverse effects induced by drugs used in tuberculosis and other mycobacterial infections. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by drugs specific for urinary tract infections. • Describes the mechanism of adverse effects induced by drugs specific for urinary tract infections. • Describes the risk factors in adverse effects induced by drugs specific for urinary tract infections. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by antiamibic drugs. • Describes the mechanism of adverse effects induced by antiamibic drugs. • Explains risk factors for adverse effects induced by antiamibic drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by antimalarial drugs. • Explains the mechanism of adverse effects induced by antimalarial drugs. • Explains risk factors for adverse effects induced by antimalarial drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by anthelmintic drugs. • Describes the mechanism of adverse effects induced by anthelmintic drugs. • Describes risk factors in adverse effects induced by anthelmintic drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by drugs used against ectoparasites. • Describes the mechanism of adverse effects induced by drugs used against ectoparasites. • Describes risk factors in adverse effects induced by drugs used against ectoparasites. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by antiviral drugs. • Describes the mechanism of adverse effects induced by antiviral drugs. • Describes risk factors in adverse effects induced by antiviral drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by antiseptics and disinfectants. • Explains the mechanism of adverse effects induced by antiseptics and disinfectants. • Describes risk factors in adverse effects induced by antiseptics and disinfectants. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions.
• Counts the adverse effects induced by cytotoxic drugs. • Describes the mechanism of adverse effects induced by cytotoxic drugs. • Explains risk factors for adverse effects induced by cytotoxic drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by sulfonamides. • Counts the adverse effects induced by hormones and hormone antagonists. • Describes the mechanism of adverse effects induced by hormones and hormone antagonists. • Explains risk factors in adverse effects induced by hormones and hormone antagonists. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by immunosuppressive drugs. • Explains the mechanism of adverse effects induced by immunosuppressive drugs. • Explains risk factors in adverse effects induced by immunosuppressive drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by immunostimulating drugs. • Explains the mechanism of adverse effects induced by immunostimulating drugs. • Describes risk factors in adverse effects induced by immunostimulant drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions.
Will able to evaluate the respiratory system drugs from a toxicological perspective.
• Counts adverse effects induced by antitussive drugs. • Describes the mechanism of adverse effects induced by antitussive drugs. • Describes the risk factors in adverse effects induced by antitussive drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by expectorants. • Explains the mechanism of adverse effects induced by expectorants. • Explains risk factors for adverse effects induced by expectorants. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by mucolytic drugs. • Describes the mechanism of adverse effects induced by mucolytic drugs. • Describes the risk factors in adverse effects induced by mucolytic drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts the adverse effects induced by surfactants. • Explains the mechanism of adverse effects induced by surfactants. • Explains the risk factors for adverse effects induced by surfactants. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions. • Counts adverse effects induced by bronchodilators and other anti-asthmatic drugs. • Describes the mechanism of adverse effects induced by bronchodilator and other anti-asthmatic drugs. • Describes risk factors in adverse effects induced by bronchodilator and other anti-asthmatic drugs. • Counts drug-drug and drug-food interactions. • Explains drug-drug and drug-food interactions.